Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pre-habilitation Program for Women Indicated to Breast Cancer Surgical Treatment.

NCT04861220 is registered in ClinicalTrials.gov with Instituto Nacional de Cancer, Brazil as lead sponsor.

NCT NCT04861220
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04861220 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pre-habilitation Program for Women Indicated to Breast Cancer Surgical Treatment.
Lead sponsor
Instituto Nacional de Cancer, Brazil
Phase
Not applicable
Overall status
Unknown status
Start date
January 1, 2022
Completion date
December 30, 2023
Enrollment
248 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast neoplasm